Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors

British Journal of Cancer
J S L KlothR H J Mathijssen

Abstract

Tyrosine kinase inhibitors (TKIs) are associated with prolongation of the QTc interval on the electrocardiogram (ECG). The QTc-interval prolongation increases the risk of life-threatening arrhythmias. However, studies evaluating the effects of TKIs on QTc intervals are limited and only consist of small patient numbers. In this multicentre trial in four centres in the Netherlands and Italy we screened all patients who were treated with any TKI. To evaluate the effects of TKIs on the QTc interval, we investigated ECGs before and during treatment with erlotinib, gefitinib, imatinib, lapatinib, pazopanib, sorafenib, sunitinib, or vemurafenib. A total of 363 patients were eligible for the analyses. At baseline measurement, QTc intervals were significantly longer in females than in males (QTcfemales=404 ms vs QTcmales=399 ms, P=0.027). A statistically significant increase was observed for the individual TKIs sunitinib, vemurafenib, sorafenib, imatinib, and erlotinib, after the start of treatment (median ΔQTc ranging from +7 to +24 ms, P<0.004). The CTCAE grade for QTc intervals significantly increased after start of treatment (P=0.0003). Especially patients who are treated with vemurafenib are at increased risk of developing a QTc of...Continue Reading

References

Sep 15, 1992·The American Journal of Cardiology·A SagieD Levy
Jan 1, 1996·Journal of the American College of Cardiology·J MolnarJ E Rosenthal
Dec 24, 2002·Current Opinion in Cardiology·Nabil El-Sherif, Gioia Turitto
Apr 24, 2003·JAMA : the Journal of the American Medical Association·Arthur J Moss
Aug 5, 2005·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Stephen R BenoitDavid J Graham
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elizabeth L StrevelLillian L Siu
Nov 21, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Giuseppe CuriglianoRashmi Shah
Feb 15, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maja de Jonge, Jaap Verweij
Mar 24, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Richard KobzaPaul Erne
Oct 8, 2009·Circulation. Arrhythmia and Electrophysiology·Augustus O Grant
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carlo L BelloLee Rosen
Apr 22, 2010·Basic & Clinical Pharmacology & Toxicology·Hyang-Ae LeeKi-Suk Kim
Jun 4, 2010·Cancer Chemotherapy and Pharmacology·Anthony W TolcherPavur R Sundaresan
Jun 26, 2010·Pharmacotherapy·Edward C LiBrian F McBride
Dec 1, 2012·Biological & Pharmaceutical Bulletin·Qian DongYi-Mei Du
Apr 27, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rashmi R ShahDevron R Shah
May 28, 2013·Toxicology and Applied Pharmacology·Kimberly R DohertySarah Bacus
Aug 24, 2013·The New England Journal of Medicine·Robert J MotzerToni K Choueiri
Sep 12, 2013·Current Medical Research and Opinion·Katy E TrinkleyJames E Tisdale

❮ Previous
Next ❯

Citations

May 27, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rashmi R Shah, Joel Morganroth
Apr 28, 2016·The Canadian Journal of Cardiology·Rohit Moudgil, Edward T H Yeh
Jun 22, 2016·International Journal of Cardiology·Wan-Li ChengYi-Jen Chen
Aug 25, 2016·Expert Opinion on Drug Metabolism & Toxicology·Pascaline Boudou-RouquetteFrançois Goldwasser
Apr 12, 2017·Antioxidants & Redox Signaling·Carlo Gabriele TocchettiGiuseppe Mercuro
Nov 28, 2017·Clinical and Experimental Hypertension : CHE·Amber KemptonSakima A Smith
Jun 26, 2018·Current Heart Failure Reports·Zarina Sharalaya, Patrick Collier
Mar 4, 2020·International Journal of Molecular Sciences·Wei-Ting ChangSheng-Nan Wu
May 15, 2020·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Tienush RassafUNKNOWN Committee for Clinical Cardiovascular Medicine of the German Cardiac Society
Apr 3, 2019·International Journal of Molecular Sciences·Paola SavoiaOttavio Cremona
Jun 7, 2018·NPJ Precision Oncology·Xinqiang HanWendi Liu
Nov 3, 2020·JNCI Cancer Spectrum·Katherine DixonKasmintan A Schrader
May 30, 2021·Critical Reviews in Oncology/hematology·Stefano FogliRomano Danesi
Dec 17, 2019·Chemical Research in Toxicology·Sarah D LamoreKyle L Kolaja
Sep 3, 2021·European Journal of Pharmacology·Ling-Jun JieYan Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

© 2022 Meta ULC. All rights reserved